BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 15627227)

  • 1. Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials.
    Korenromp EL; White RG; Orroth KK; Bakker R; Kamali A; Serwadda D; Gray RH; Grosskurth H; Habbema JD; Hayes RJ
    J Infect Dis; 2005 Feb; 191 Suppl 1():S168-78. PubMed ID: 15627227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-based trials of sexually transmitted disease treatment: repercussions for epidemiology and HIV prevention.
    Hudson CP
    Bull World Health Organ; 2001; 79(1):48-58. PubMed ID: 11217667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher risk behaviour and rates of sexually transmitted diseases in Mwanza compared to Uganda may help explain HIV prevention trial outcomes.
    Orroth KK; Korenromp EL; White RG; Gavyole A; Gray RH; Muhangi L; Sewankambo NK; Quigley M; Wawer MJ; Whitworth JA; Grosskurth H; Habbema JD; Hayes RJ
    AIDS; 2003 Dec; 17(18):2653-60. PubMed ID: 14685060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study.
    White RG; Orroth KK; Korenromp EL; Bakker R; Wambura M; Sewankambo NK; Gray RH; Kamali A; Whitworth JA; Grosskurth H; Habbema JD; Hayes RJ
    J Acquir Immune Defic Syndr; 2004 Dec; 37(4):1500-13. PubMed ID: 15602129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of the Mwanza and Rakai STI trials.
    O'Farrell N
    Bull World Health Organ; 2001; 79(5):482. PubMed ID: 11417045
    [No Abstract]   [Full Text] [Related]  

  • 6. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.
    Ng BE; Butler LM; Horvath T; Rutherford GW
    Cochrane Database Syst Rev; 2011 Mar; (3):CD001220. PubMed ID: 21412869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
    Sangani P; Rutherford G; Wilkinson D
    Cochrane Database Syst Rev; 2004; (2):CD001220. PubMed ID: 15106156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
    Wilkinson D; Rutherford G
    Cochrane Database Syst Rev; 2001; (2):CD001220. PubMed ID: 11405980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation of the Mwanza and Rakai STD trials.
    Hayes R; Grosskurth H; Mabey D
    Bull World Health Organ; 2001; 79(5):482-3. PubMed ID: 11417046
    [No Abstract]   [Full Text] [Related]  

  • 10. Sexually transmitted infections: prevention and management.
    Jackson D; Dallabetta G; Steen R
    Clin Occup Environ Med; 2004 Feb; 4(1):167-88. PubMed ID: 15043369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical models.
    Boily MC; Bastos FI; Desai K; Mâsse B
    Sex Transm Dis; 2004 Feb; 31(2):100-13. PubMed ID: 14743073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials.
    Grosskurth H; Gray R; Hayes R; Mabey D; Wawer M
    Lancet; 2000 Jun; 355(9219):1981-7. PubMed ID: 10859054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing HIV infection: lessons from Mwanza and Rakai.
    Hitchcock P; Fransen L
    Lancet; 1999 Feb; 353(9152):513-5. PubMed ID: 10028974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mwanza trial: Dr. Hudson replies.
    Hudson CP
    Bull World Health Organ; 2001; 79(8):793-4. PubMed ID: 11545339
    [No Abstract]   [Full Text] [Related]  

  • 15. A community-based study to examine the effect of a youth HIV prevention intervention on young people aged 15-24 in South Africa: results of the baseline survey.
    Pettifor AE; Kleinschmidt I; Levin J; Rees HV; MacPhail C; Madikizela-Hlongwa L; Vermaak K; Napier G; Stevens W; Padian NS
    Trop Med Int Health; 2005 Oct; 10(10):971-80. PubMed ID: 16185231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of discordant reports of sexual and HIV/sexually transmitted infection risk behaviors among heterosexual couples.
    Witte SS; El-Bassel N; Gilbert L; Wu E; Chang M
    Sex Transm Dis; 2007 May; 34(5):302-8. PubMed ID: 17016237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexually transmitted infections knowledge and its impact in the practice of risky sexual behaviours and HIV serostatus: results from rural Kilimanjaro, Tanzania.
    Mmbaga EJ; Leyna GH; Mnyika KS; Klepp KI
    Sex Transm Infect; 2008 Jun; 84(3):224-6. PubMed ID: 18283095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted interventions required against genital ulcers in African countries worst affected by HIV infection.
    O'Farrell N
    Bull World Health Organ; 2001; 79(6):569-77. PubMed ID: 11436480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexually transmitted infections in Western Europe among HIV-positive men who have sex with men.
    Dougan S; Evans BG; Elford J
    Sex Transm Dis; 2007 Oct; 34(10):783-90. PubMed ID: 17495592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV epidemic in Estonia in the third decade of the AIDS era.
    Rüütel K; Uusküla A
    Scand J Infect Dis; 2006; 38(3):181-6. PubMed ID: 16507499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.